MIRA Pharmaceuticals, Inc. Basic Shares Outstanding (Weighted Average)
MIRA Pharmaceuticals, Inc. (MIRA) reported Basic Shares Outstanding (Weighted Average) of 42.02 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- MIRA Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 42.02M shares, a 147.39% increase year-over-year.
- MIRA Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 41.94M shares, a 151.97% increase year-over-year.
- MIRA Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 40.82M shares, a 146.51% increase year-over-year.
- MIRA Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 19.27M shares, a 27.89% increase year-over-year.
- MIRA Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 23.69M shares, a 53.42% increase from fiscal 2024.
- MIRA Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 15.44M shares, a 10.91% increase from fiscal 2023.
- MIRA Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 13.92M shares, a 20.73% decline from fiscal 2022.
- MIRA Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 17.57M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 42.02M shares 10-Q · filed 2026-08-12 | 41.98M shares 10-Q · filed 2026-08-12 | 41.60M shares derived: average of 3 quarters · filed 2026-08-12 | 36.02M shares derived: average of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | 41.94M shares 10-Q · filed 2026-05-14 | 41.38M shares derived: average of 2 quarters · filed 2026-05-14 | 34.01M shares derived: average of 3 quarters · filed 2026-05-14 | 29.76M shares derived: average of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | 40.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 30.05M shares derived: average of 2 quarters · filed 2026-03-31 | 25.69M shares derived: average of 3 quarters · filed 2026-08-12 | 23.69M shares 10-K · filed 2026-03-31 | ||
| 2025-09-30 | 19.27M shares 10-Q · filed 2025-11-13 | 18.13M shares derived: average of 2 quarters · filed 2026-08-12 | 17.98M shares 10-Q · filed 2025-11-13 | 17.37M shares derived: average of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | 16.99M shares 10-Q · filed 2026-08-12 | 17.36M shares 10-Q · filed 2026-08-12 | 16.73M shares derived: average of 3 quarters · filed 2026-08-12 | 16.32M shares derived: average of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | 16.65M shares 10-Q · filed 2026-05-14 | 16.60M shares derived: average of 2 quarters · filed 2026-05-14 | 16.09M shares derived: average of 3 quarters · filed 2026-05-14 | 15.76M shares derived: average of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | 16.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 15.82M shares derived: average of 2 quarters · filed 2026-03-31 | 15.47M shares derived: average of 3 quarters · filed 2026-03-31 | 15.44M shares 10-K · filed 2026-03-31 | ||
| 2024-09-30 | 15.07M shares 10-Q · filed 2025-11-13 | 14.93M shares derived: average of 2 quarters · filed 2025-11-13 | 15.07M shares 10-Q · filed 2025-11-13 | 14.85M shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 14.78M shares 10-Q · filed 2025-08-14 | 14.78M shares 10-Q · filed 2025-08-14 | 14.78M shares derived: average of 3 quarters · filed 2025-08-14 | 14.50M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 14.78M shares 10-Q · filed 2025-05-14 | 19.71M shares 10-Q · filed 2024-05-13 | 14.78M shares derived: average of 2 quarters · filed 2025-05-14 | 14.40M shares derived: average of 3 quarters · filed 2025-05-14 | 14.13M shares derived: average of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | 14.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 14.21M shares derived: average of 2 quarters · filed 2025-03-28 | 13.91M shares derived: average of 3 quarters · filed 2025-03-28 | 13.92M shares 10-K · filed 2025-03-28 | 18.57M shares 10-K · filed 2024-04-01 | |
| 2023-09-30 | 13.64M shares 10-Q · filed 2024-11-12 | 13.48M shares derived: average of 2 quarters · filed 2024-11-12 | 13.64M shares 10-Q · filed 2024-11-12 | 18.87M shares derived: average of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | 13.31M shares 10-Q/A · filed 2024-08-16 | 13.31M shares 10-Q/A · filed 2024-08-16 | 20.61M shares derived: average of 3 quarters · filed 2024-08-16 | 18.75M shares derived: average of 4 quarters · filed 2024-08-16 | ||
| 2023-03-31 | 17.75M shares 10-Q · filed 2024-05-13 | 24.26M shares derived: average of 2 quarters · filed 2024-05-13 | 20.56M shares derived: average of 3 quarters · filed 2024-05-13 | 18.69M shares derived: average of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | 30.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 21.97M shares derived: average of 2 quarters · filed 2024-04-01 | 19.01M shares derived: average of 3 quarters · filed 2024-04-01 | 17.57M shares 10-K · filed 2024-04-01 | ||
| 2022-09-30 | 13.17M shares 10-Q · filed 2023-11-13 | 13.13M shares derived: average of 2 quarters · filed 2023-11-13 | 13.17M shares 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | 13.09M shares 10-Q · filed 2023-09-15 | 13.08M shares 10-Q · filed 2023-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |